Orphan drug designation in Europe: A booster for the research and development of drugs in rare diseases
Joëlle Micallef, Olivier Blin
Topics & Concepts
Orphan drugIncentiveEuropean unionAgency (philosophy)Protocol (science)BusinessProduct (mathematics)MedicinePolitical sciencePublic relationsAlternative medicineInternational tradeEconomicsBioinformaticsMathematicsEpistemologyPathologyMicroeconomicsBiologyGeometryPhilosophyGenomics and Rare DiseasesBiotechnology and Related FieldsHealth Systems, Economic Evaluations, Quality of Life